Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 92

1.

Band Structure Engineering of Layered WSe2 via One-Step Chemical Functionalization.

Park JH, Rai A, Hwang J, Zhang C, Kwak I, Wolf SF, Vishwanath S, Liu X, Dobrowolska M, Furdyna J, Xing HG, Cho K, Banerjee SK, Kummel AC.

ACS Nano. 2019 Jul 23;13(7):7545-7555. doi: 10.1021/acsnano.8b09351. Epub 2019 Jul 1.

PMID:
31260257
2.

Atomic Layer Deposition of Al2O3 on WSe2 Functionalized by Titanyl Phthalocyanine.

Park JH, Fathipour S, Kwak I, Sardashti K, Ahles CF, Wolf SF, Edmonds M, Vishwanath S, Xing HG, Fullerton-Shirey SK, Seabaugh A, Kummel AC.

ACS Nano. 2016 Jul 26;10(7):6888-96. doi: 10.1021/acsnano.6b02648. Epub 2016 Jun 29.

PMID:
27305595
3.

Determination of 11 major and minor elements in chondritic meteorites by inductively coupled plasma mass spectrometry.

Wolf SF, Compton JR, Gagnon CJ.

Talanta. 2012 Oct 15;100:276-81. doi: 10.1016/j.talanta.2012.07.038. Epub 2012 Aug 10.

PMID:
23141337
4.

Cytosolic phospholipase A2α blockade abrogates disease during the tissue-damage effector phase of experimental autoimmune encephalomyelitis by its action on APCs.

Thakker P, Marusic S, Stedman NL, Lee KL, McKew JC, Wood A, Goldman SJ, Leach MW, Collins M, Kuchroo VK, Wolf SF, Clark JD, Hassan-Zahraee M.

J Immunol. 2011 Aug 15;187(4):1986-97. doi: 10.4049/jimmunol.1002789. Epub 2011 Jul 11.

5.

FIZZ1 potentiates the carbachol-induced tracheal smooth muscle contraction.

Chen H, Jacobson BA, Mason L, Wolf SF, Bowman MR.

Eur Respir J. 2010 Nov;36(5):1165-73. doi: 10.1183/09031936.00097609. Epub 2010 Apr 22.

6.

Evolutionary and biochemical differences between human and monkey acidic mammalian chitinases.

Krykbaev R, Fitz LJ, Reddy PS, Winkler A, Xuan D, Yang X, Fleming M, Wolf SF.

Gene. 2010 Mar 1;452(2):63-71. doi: 10.1016/j.gene.2009.12.005. Epub 2009 Dec 28.

PMID:
20036323
7.

MMP dependence of fibroblast contraction and collagen production induced by human mast cell activation in a three-dimensional collagen lattice.

Margulis A, Nocka KH, Wood NL, Wolf SF, Goldman SJ, Kasaian MT.

Am J Physiol Lung Cell Mol Physiol. 2009 Feb;296(2):L236-47. doi: 10.1152/ajplung.90462.2008. Epub 2008 Dec 5.

8.

Blockade of cytosolic phospholipase A2 alpha prevents experimental autoimmune encephalomyelitis and diminishes development of Th1 and Th17 responses.

Marusic S, Thakker P, Pelker JW, Stedman NL, Lee KL, McKew JC, Han L, Xu X, Wolf SF, Borey AJ, Cui J, Shen MW, Donahue F, Hassan-Zahraee M, Leach MW, Shimizu T, Clark JD.

J Neuroimmunol. 2008 Nov 15;204(1-2):29-37. doi: 10.1016/j.jneuroim.2008.08.012.

PMID:
18829119
9.

Pillars article: development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. 1993. Science 260(5107): 547-549.

Hsieh CS, Macatonia SE, Tripp CS, Wolf SF, O'Garra A, Murphy KM.

J Immunol. 2008 Oct 1;181(7):4437-9. No abstract available.

10.

Geochemical and cosmochemical materials.

Lipschutz ME, Wolf SF, Culp FB, Kent AJ.

Anal Chem. 2007 Jun 15;79(12):4249-74. Epub 2007 May 4. No abstract available.

PMID:
17477509
11.

Modulation of the IL-12/IFN-gamma axis by IFN-alpha therapy for hepatitis C.

Byrnes AA, Li DY, Park K, Thompson D, Mocilnikar C, Mohan P, Molleston JP, Narkewicz M, Zhou H, Wolf SF, Schwarz KB, Karp CL.

J Leukoc Biol. 2007 Mar;81(3):825-34. Epub 2006 Dec 15.

PMID:
17148690
12.

A directly labeled TR-FRET assay for monitoring phosphoinositide-3-kinase activity.

Yang X, Li P, Feldberg L, Kim SC, Bowman M, Hollander I, Mallon R, Wolf SF.

Comb Chem High Throughput Screen. 2006 Aug;9(7):565-70.

PMID:
16925516
13.

A homogeneous time-resolved fluorescence resonance energy transfer assay for IL-13/IL-13Ralpha1 interaction.

Yang X, Capotosto R, DiBlasio E, Hu Z, Kriz R, Lorenzo M, Malakian K, Wolfrom S, Wilhelm J, Wolf SF.

Anal Biochem. 2006 Apr 1;351(1):158-60. Epub 2006 Jan 13. No abstract available.

PMID:
16460661
14.

The anti-tumor effect of interleukin-12 is enhanced by mild (fever-range) thermal therapy.

Pritchard MT, Wolf SF, Kraybill WF, Repasky EA.

Immunol Invest. 2005;34(3):361-80.

PMID:
16136786
15.

Combined antiangiogenic and immune therapy of prostate cancer.

Huang X, Raskovalova T, Lokshin A, Krasinskas A, Devlin J, Watkins S, Wolf SF, Gorelik E.

Angiogenesis. 2005;8(1):13-23.

PMID:
16132614
16.

Geochemical and cosmochemical materials.

Lipschutz ME, Wolf SF, Culp FB, Hanchar JM.

Anal Chem. 2005 Jun 15;77(12):3717-36. No abstract available.

PMID:
15952753
17.

Virulent Toxoplasma gondii strain RH promotes T-cell-independent overproduction of proinflammatory cytokines IL12 and gamma-interferon.

Nguyen TD, Bigaignon G, Markine-Goriaynoff D, Heremans H, Nguyen TN, Warnier G, Delmee M, Warny M, Wolf SF, Uyttenhove C, Van Snick J, Coutelier JP.

J Med Microbiol. 2003 Oct;52(Pt 10):869-76.

PMID:
12972580
18.

Intranasal IL-12 produces discreet pulmonary and systemic effects on allergic inflammation and airway reactivity.

Matsuse H, Kong X, Hu J, Wolf SF, Lockey RF, Mohapatra SS.

Int Immunopharmacol. 2003 Apr;3(4):457-68.

PMID:
12689651
19.

Capacity of murine IL-12 to inhibit the development of primary melanoma tumors and to prevent lung metastases in the melanoma-challenged mice.

Shrayer DP, Bogaars H, Cole B, Wolf SF, Wanebo HJ.

J Exp Ther Oncol. 2002 Mar-Apr;2(2):93-9.

PMID:
12415625
20.
21.

Efficacy and mechanisms of action of rmB7.2-Ig as an antitumor agent in combination with Adriamycin and Cytoxan chemotherapy.

Zhou H, Sequeira M, Goad ME, Erickson J, Wong A, Clark E, Dunussi-Joannopoulos K, Li RC, Friedrich S, Hayes LL, Wolf SF.

Clin Immunol. 2001 Dec;101(3):303-14.

PMID:
11726223
22.

Type I interferons and IL-12: convergence and cross-regulation among mediators of cellular immunity.

Byrnes AA, Ma X, Cuomo P, Park K, Wahl L, Wolf SF, Zhou H, Trinchieri G, Karp CL.

Eur J Immunol. 2001 Jul;31(7):2026-34.

23.

Geochemical and cosmochemical materials.

Lipschutz ME, Wolf SF, Hanchar JM, Culp FB.

Anal Chem. 2001 Jun 15;73(12):2687-99. No abstract available.

PMID:
11432697
24.

Dose-dependent and schedule-dependent effects of interleukin-12 on antigen-specific CD8 responses.

Lee K, Overwijk WW, O'Toole M, Swiniarski H, Restifo NP, Dorner AJ, Wolf SF, Sturmhoefel K.

J Interferon Cytokine Res. 2000 Jun;20(6):589-96.

25.

Cytokines and cancer immunotherapy.

Wolf SF, Lee K, Swiniarski H, O'Toole M, Sturmhoefel K.

Immunol Invest. 2000 May;29(2):143-6. Review. No abstract available.

PMID:
10854183
26.

IL-12-Dependent enhancement of CTL response to weak class I-restricted peptide immunogens requires coimmunization with T helper cell immunogens.

Swiniarski H, Wolf SF, Sturmhoefel K, Peterson RL, Dorner AJ, O'Toole M.

Clin Immunol. 2000 Mar;94(3):200-11.

PMID:
10692239
27.

A CTL assay requiring only 150 microliter of mouse blood.

Swiniarski H, Sturmhoefel K, Lee K, Wolf SF, Dorner AJ, O'Toole M.

J Immunol Methods. 2000 Jan 13;233(1-2):1-11.

PMID:
10648850
28.

Potent activity of soluble B7-IgG fusion proteins in therapy of established tumors and as vaccine adjuvant.

Sturmhoefel K, Lee K, Gray GS, Thomas J, Zollner R, O'Toole M, Swiniarski H, Dorner A, Wolf SF.

Cancer Res. 1999 Oct 1;59(19):4964-72.

29.

Immune response enhancement by in vivo administration of B7.2Ig, a soluble costimulatory protein.

Swiniarski H, Sturmhoefel K, Lee K, Gray GS, Thomas JL, Wolf SF, Dorner AJ, O'Toole M.

Clin Immunol. 1999 Sep;92(3):235-45.

PMID:
10479528
30.

Immunotherapy of mice with an irradiated melanoma vaccine coupled with interleukin-12.

Shrayer DP, Cole B, Hearing VJ, Wolf SF, Wanebo HJ.

Clin Exp Metastasis. 1999 Feb;17(1):63-70.

PMID:
10390149
31.

Geochemical and cosmochemical materials.

Lipschutz ME, Wolf SF, Hanchar JM, Culp FB.

Anal Chem. 1999 Jun 15;71(12):1R-20R. Review. No abstract available.

PMID:
10384779
32.
33.

A new mouse model of experimental melanoma for vaccine and lymphokine therapy.

Shrayer DP, Bogaars H, Wolf SF, Hearing VJ, Wanebo HJ.

Int J Oncol. 1998 Aug;13(2):361-74.

PMID:
9664134
34.

Acute and chronic phases of Toxoplasma gondii infection in mice modulate the host immune responses.

Nguyen TD, Bigaignon G, Van Broeck J, Vercammen M, Nguyen TN, Delmee M, Turneer M, Wolf SF, Coutelier JP.

Infect Immun. 1998 Jun;66(6):2991-5.

35.

IL-12 induces IFN-gamma expression and secretion in mouse peritoneal macrophages.

Puddu P, Fantuzzi L, Borghi P, Varano B, Rainaldi G, Guillemard E, Malorni W, Nicaise P, Wolf SF, Belardelli F, Gessani S.

J Immunol. 1997 Oct 1;159(7):3490-7.

PMID:
9317148
36.

Interleukin-12 as vaccine adjuvant. Characteristics of primary, recall, and long-term responses.

Bliss J, Maylor R, Stokes K, Murray KS, Ketchum MA, Wolf SF.

Ann N Y Acad Sci. 1996 Oct 31;795:26-35. No abstract available.

PMID:
8958914
37.

Interleukin (IL)-12 deficiency in susceptible mice infected with Mycobacterium avium and amelioration of established infection by IL-12 replacement therapy.

Kobayashi K, Yamazaki J, Kasama T, Katsura T, Kasahara K, Wolf SF, Shimamura T.

J Infect Dis. 1996 Sep;174(3):564-73.

PMID:
8769615
38.

Interleukin-12 production by human monocytes infected with Mycobacterium tuberculosis: role of phagocytosis.

Fulton SA, Johnsen JM, Wolf SF, Sieburth DS, Boom WH.

Infect Immun. 1996 Jul;64(7):2523-31.

39.

Genetic mapping of the IL-12 alpha chain gene (Il12a) on mouse chromosome 3.

Schweitzer PA, Noben-Trauth N, Pelsue SC, Johnson KR, Wolf SF, Shultz LD.

Mamm Genome. 1996 May;7(5):394-5. No abstract available.

PMID:
8661735
40.

The interleukin-12 beta subunit (p40) maps to mouse chromosome 11.

Noben-Trauth N, Schweitzer PA, Johnson KR, Wolf SF, Knowles BB, Shultz LD.

Mamm Genome. 1996 May;7(5):392. No abstract available.

PMID:
8661733
41.

Interleukin-12 stimulates B cell growth by inducing IFN-gamma.

Li L, Young D, Wolf SF, Choi YS.

Cell Immunol. 1996 Mar 15;168(2):133-40.

PMID:
8640858
42.

IL-12, as an adjuvant, promotes a T helper 1 cell, but does not suppress a T helper 2 cell recall response.

Bliss J, Van Cleave V, Murray K, Wiencis A, Ketchum M, Maylor R, Haire T, Resmini C, Abbas AK, Wolf SF.

J Immunol. 1996 Feb 1;156(3):887-94.

PMID:
8558014
43.

The interleukin 12 p40 gene promoter is primed by interferon gamma in monocytic cells.

Ma X, Chow JM, Gri G, Carra G, Gerosa F, Wolf SF, Dzialo R, Trinchieri G.

J Exp Med. 1996 Jan 1;183(1):147-57.

44.

Activity of IL12 as adjuvant in promoting Th1 and Th2 recall responses.

Wolf SF, Bliss J, Stokes K, Sypek J.

Res Immunol. 1995 Sep-Oct;146(7-8):486-9. Review. No abstract available.

PMID:
8839151
45.
46.

Interleukin 12 suppresses autoantibody production by reversing helper T-cell phenotype in hepatitis B e antigen transgenic mice.

Milich DR, Wolf SF, Hughes JL, Jones JE.

Proc Natl Acad Sci U S A. 1995 Jul 18;92(15):6847-51.

47.

Systemic administration of rIL-12 induces complete tumor regression and protective immunity: response is correlated with a striking reversal of suppressed IFN-gamma production by anti-tumor T cells.

Zou JP, Yamamoto N, Fujii T, Takenaka H, Kobayashi M, Herrmann SH, Wolf SF, Fujiwara H, Hamaoka T.

Int Immunol. 1995 Jul;7(7):1135-45.

PMID:
8527411
48.

IL-12 inhibits the production of IL-4 and IL-10 in allergen-specific human CD4+ T lymphocytes.

Marshall JD, Secrist H, DeKruyff RH, Wolf SF, Umetsu DT.

J Immunol. 1995 Jul 1;155(1):111-7.

PMID:
7602091
49.
50.

Interleukin-12 gene expression after viral infection in the mouse.

Coutelier JP, Van Broeck J, Wolf SF.

J Virol. 1995 Mar;69(3):1955-8.

Supplemental Content

Support Center